AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2023
Aug 14, 2023
34576_dirs_2023-08-14_a07508d4-b6f1-4d2e-b47c-33595349c69a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-08-10
Reporting Person: Schoeneck James A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-10 | Stock Option (Right to Buy) | $1.44 | A | 10000 | Acquired | 2033-08-10 | Common Stock (10000) | Direct |
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10